Pharming Group N.V.
PHAR
$11.72
-$0.63-5.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | 38.46% | 38.46% |
| Total Depreciation and Amortization | -- | -- | -- | -4.26% | -4.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -3.62% | -3.62% |
| Total Other Non-Cash Items | -- | -- | -- | 122.99% | 152.51% |
| Change in Net Operating Assets | -- | -- | -- | 101.78% | 78.80% |
| Cash from Operations | -- | -- | -- | 638.65% | 638.65% |
| Capital Expenditure | -- | -- | -- | -21.61% | -21.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 427.09% | 427.09% |
| Cash from Investing | -- | -- | -- | 184.56% | 184.56% |
| Total Debt Issued | -- | -- | -- | -100.25% | -100.25% |
| Total Debt Repaid | -- | -- | -- | 96.89% | 96.89% |
| Issuance of Common Stock | -- | -- | -- | -72.24% | -72.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -90.85% | -90.85% |
| Cash from Financing | -- | -- | -- | 50.62% | 50.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 1,290.16% | 1,290.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 177.65% | 177.65% |